Novartis’s NASH Chief: Our Strategy Is Combos With Tropifexor As ‘Backbone’

 
• By Sten Stovall
Liver
Novartis's NASH Chief Says Program is gradually growing • Source: Shutterstock

More from Alimentary/Metabolic

More from Therapeutic Category